We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure [email protected]
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Edited by
Dharti Patel, Mount Sinai West and Morningside Hospitals, New York,Sang J. Kim, Hospital for Special Surgery, New York,Himani V. Bhatt, Mount Sinai West and Morningside Hospitals, New York,Alopi M. Patel, Rutgers Robert Wood Johnson Medical School, New Jersey
Lower respiratory tract disorders, which include pulmonary disorders like asthma and chronic obstructive pulmonary disease (COPD), are prevalent. This chapter discusses the pharmacology of some of the important classes of drugs used to treat these conditions. Bronchodilators relax smooth muscles and expand airways. Beta-2 agonists and anticholinergics are the two most commonly used bronchodilators used for this purpose. They are available in both short-acting and long-acting formulations. Short-acting (e.g. albuterol) are used as required for sudden episodes of breathlessness, while long-acting may be added if symptoms are not controlled or progress. Bronchodilators help to improve a patient’s overall quality of life through improved lung function, a decrease in symptoms, and improved exercise capacity. Corticosteroids, leukotriene modifiers, mast cell stabilizers, and Immunoglobulin E (IgE) blockers are classes of anti-inflammatory medications that have been shown to be effective treatments in controlling asthma symptoms and attacks. Research and experience have shown that a combination of these medications may be required. This can particularly be true for patients with intermediate and severe symptoms where a single medication has been inadequate in controlling/preventing recurrent symptoms.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.